The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...

For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant schizophrenia, and the only one it recognizes as reducing the risk of suicide. This ...

Clozapine, which was approved in 1989, is regarded by many physicians as the most effective available treatment for schizophrenia, and research shows that the drug significantly reduces suicidal ...

When Texas legalized hemp in 2019, it inadvertently approved the sale of hemp-derived consumable products with up to 0.3% THC ...

The decision was supported by a randomised, six-week, placebo-controlled trial involving 316 adolescent subjects.

Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

According to a 2024 review, cannabis use, especially in high doses, can cause a short-lived psychotic reaction in people without schizophrenia. As the drug wears off, the symptoms fade.

a group with a dual pathology of schizophrenia with cannabis abuse, and a control group of individuals with neither a psychiatric disorder nor drug use," explained Dr Urigüen. In the study they ...